- January 14, 2021
-
Morinaga Milk Unveils New Research on the Improved Effects of Lactoferrin-fortified Formula on Sleep Quality in Children (PDF573KB)
- November 11, 2020
-
Announcement of Financial Results for the First Half of the Fiscal Year Ending March 31, 2021.
- October 27, 2020
-
Morinaga Milk’s Probiotic Bifidobacterium longum BB536 Wins 2020 NutraIngredients-Asia Award for ‘Editors’ Award for the Infant & Child Nutrition of the Year’（PDF571KB）
- October 27, 2020
-
Expansion of Lactoferrin Production Capacity in German Subsidiary “MILEI GmbH”（PDF295KB）
- August 12, 2020
-
Announcement of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2021.
- August 03, 2020
-
Notice Regarding Completion of Payment for Issuance of New Sharesas Restricted Stock Compensation (PDF83KB)
- July 14, 2020
-
Notice Regarding Issuance of New Shares as Restricted Stock Compensation(PDF112KB)
- July 09, 2020
-
New Evidence Shows Morinaga Milk’s Probiotic Bifidobacterium breve A1 Improves Memory of Older Adults with Cognitive Dysfunction(PDF343KB)
- June 17, 2020
-
Morinaga Milk Unveils New Research on the Protective Effects of Lactoferrin-fortified Formula on Acute Gastrointestinal Symptoms in Children(PDF321KB)
- May 26, 2020
-
Notice of the 97th Annual General Meeting of Shareholders(PDF1,342KB)
